Overview
Global Business Reports featured Steptoe New York partner Vishal Gupta in a Q&A interview. In the article, published in the 2018 United States Biopharmaceuticals issue, Gupta discusses how the United States' IP protection framework affects the dynamics between branded and generic drugs. He also mentions major developments in biosimilars guidelines.
The full interview can be read at Global Business Reports.
